Synergy of Host Defense Mechanisms in the Lung
Synergy of Host Defense Mechanisms in the Lung
批准号:
10559622
负责人:
Arturo Casadevall
金额:
$40.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-09-30 至 2025-01-31
关键词:
AccidentsAffectAlveolar MacrophagesAmoeba genusAnimalsAntifungal AgentsAntifungal TherapyBrainCell DeathCellsCessation of lifeCryptococcosisCryptococcusCryptococcus neoformansCryptococcus neoformans infectionDataDesiccationDiseaseEffector CellElementsEnvironmentEquus caballusEukaryotaExocytosisFishesFundingGoalsGranulomaGrowthHost DefenseHost Defense MechanismHumanImmuneImmune systemImmunityImmunocompetentImmunocompromised HostImpairmentIn VitroIndividualInfectionInfection ControlIngestionInhalationInsectaIntegration Host FactorsInvadedLifeLungMacrophageMacrophage ActivationMammalsMembraneMeningoencephalitisMitochondriaMolecularMorbidity - disease rateMothsMusNational Heart, Lung, and Blood InstituteNonlyticOrganismOutcomePathogenesisPathogenicityPhagocytesPhagocytosisPhagosomesPlantsPredispositionProcessProductionProteinsProtozoaRattusReproduction sporesResistanceRoleSeverity of illnessSoilSystemTimeTissuesTranslationsUreaseVaccinesVirulenceVirulence FactorsVirulentWorkYeastsYincell killingdesignfascinatefungushuman pathogenimprovedin vivomicrobialmortalitynovel strategiesparticlepathogenpathogenic funguspressurepreventprogramsrespiratory pathogensynergismtrait
中文摘要
新生隐球菌是一种比较常见的呼吸道病原体。
免疫力受损的人罹患危及生命的疾病的原因。巨噬细胞
关键细胞在控制和传播肺部感染中的作用。新生革兰氏菌是一种
一种兼性细胞内病原体,可在破坏巨噬细胞后在巨噬细胞中复制
吞噬体膜。真菌对吞噬体膜的损伤决定了
真菌-巨噬细胞相互作用的结果。对于新生葡萄球菌,以及其他土壤
病原真菌,毒力的能力已经被认为是通过与
环境中的吞噬捕食者,它们选择特征,然后可以促进毒力
哺乳动物。事实上,新生芽孢杆菌发病机制的一个显著方面是它是
在许多不同的动物宿主中具有毒力,并可以在哺乳动物的吞噬细胞中复制,
鱼、昆虫和原生动物。这提出了一个令人着迷的问题:没有
对动物宿主的需要能够颠覆如此多物种的免疫效应细胞。我们
假设这种非特定毒力的能力来自于它破坏
宿主细胞,其中包括细胞内分泌的
大量的效应器分子。我们有初步数据表明,新月芽孢杆菌释放出许多
小鼠巨噬细胞内的蛋白质,包括几个众所周知的毒力因子。在这
我们提出的应用于鉴定人巨噬细胞和阿米巴内产生的蛋白质
破坏宿主细胞。然后对这些蛋白质的一个子集进行详细研究,以进行剖析
细胞内致病机制。提出了三个具体目标:目标1.确定
人巨噬细胞内产生的CN蛋白;目的2.鉴定关键CN
与阿米巴相互作用产生的化合物;目的3.确定阿米巴的作用机制
某些CN蛋白在吞噬细胞内致病策略中的作用
原生动物细胞。这项工作将阐明新生隐孢子菌的胞内机制。
发病机制和这些信息可能与设计改进的治疗方法、抗真菌药物有关
治疗和疫苗。
英文摘要
The fungus Cryptococcus neoformans is a respiratory pathogen that is a relatively frequent
cause of life-threatening disease in individuals with impaired immunity. Macrophages are
critical cells in the control and dissemination of infection in the lung. C. neoformans is a
facultative intracellular pathogen that can replicate in macrophage after damaging the
phagolysosomal membrane. Fungal damage to the phagolysosomal membrane determines the
outcome of the fungal-macrophage interaction. For C. neoformans, as well as other soil
pathogenic fungi, the capacity for virulence has been proposed to emerge from interactions with
phagocytic predators in the environment that select for traits that can then promote virulence in
mammals. In fact, one of the remarkable aspects of C. neoformans pathogenesis is that it is
virulent in many different animal hosts and can replicate in phagocytic cells from mammals,
fish, insects and protozoa. This poses the fascinating question of how a soil organism with no
need for an animal host is able to subvert immune effector cells from so many species. We
hypothesize that this capacity for non-specific virulence comes from its ability to undermine
host cells with an ‘intracellular pathogenesis kit’ that includes the intracellular secretion of
numerous effector molecules. We have preliminary data that C. neoformans releases many
proteins inside murine macrophages that include several well-known virulence factors. In this
application we propose to identify proteins made inside human macrophages and amoeba that
undermine host cells. A subset of these proteins will then be studied in detail to dissect
mechanisms of intracellular pathogenesis. Three specific aims are proposed: Aim 1. To identify
CN proteins produced intracellularly in human macrophages; Aim 2. To identify key CN
compounds produced during its interaction with amoeba; Aim 3. To ascertain the mechanism of
action of certain CN proteins in the intracellular pathogenic strategy in phagocytic human and
protozoan cells. This work will illuminate the mechanisms of C. neoformans intracellular
pathogenesis and this information can be relevant to designing improved therapies, antifungal
therapies and vaccines.
期刊论文(399)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.
荚膜多糖抗体在新型隐球菌感染中的作用机制。
DOI:
10.2741/a270
发表时间:
1998
期刊:
Frontiers in bioscience : a journal and virtual library
影响因子:
--
作者:
[Feldmesser,M, Casadevall,A]
通讯作者:
Casadevall,A
A food color based colorimetric assay for Cryptococcus neoformans laccase activity.
基于食品颜色的新型隐球菌漆酶活性比色测定。
DOI:
10.1101/2024.01.01.573823
发表时间:
2024
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Ramirez,LiaSanchez, Dragotakes,Quigly, Casadevall,Arturo]
通讯作者:
Casadevall,Arturo
Semi-synthetic glycoconjugate vaccine candidate against Cryptococcus neoformans.
针对新型隐球菌的半合成复合糖疫苗候选物。
DOI:
10.1101/2024.02.02.578725
发表时间:
2024
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Crawford,ConorJ, Liporagi-Lopes,Livia, Coelho,Carolina, Santos,SamuelR, Nicola,AndréMoraes, Wear,MaggieP, Vij,Raghav, Oscarson,Stefan, Casadevall,Arturo]
通讯作者:
Casadevall,Arturo
Melanization of Cryptococcus neoformans in murine infection.
小鼠感染中新型隐球菌的黑化。
DOI:
10.1128/mcb.19.1.745
发表时间:
1999
期刊:
Molecular and cellular biology
影响因子:
5.3
作者:
[Nosanchuk,JD, Valadon,P, Feldmesser,M, Casadevall,A]
通讯作者:
Casadevall,A
The structure of a C. neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study.
保护性抗体识别的新型隐球菌多糖基序的结构:NMR 和 MD 联合研究。
DOI:
10.1101/2023.09.06.556507
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Hargett,AudraA, Azurmendi,HugoF, Crawford,ConorJ, Wear,MaggieP, Oscarson,Stefan, Casadevall,Arturo, Freedberg,DarόnI]
通讯作者:
Freedberg,DarόnI
共 181 条
The biology of Cryptococcus neoformans melanization
-
批准号:10660435
-
项目类别:
-
资助金额:$84.15万
-
财政年份:2023
-
负责人:Arturo Casadevall
-
依托单位:
Exploiting antibody catalysis for treating Cryptococcosis
-
批准号:10326944
-
项目类别:
-
资助金额:$73.41万
-
财政年份:2021
-
负责人:Arturo Casadevall
-
依托单位:
Exploiting antibody catalysis for treating Cryptococcosis
-
批准号:10410573
-
项目类别:
-
资助金额:$75.78万
-
财政年份:2021
-
负责人:Arturo Casadevall
-
依托单位:
Exploiting antibody catalysis for treating Cryptococcosis
-
批准号:10609085
-
项目类别:
-
资助金额:$75.58万
-
财政年份:2021
-
负责人:Arturo Casadevall
-
依托单位:
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement
-
批准号:10265635
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2020
-
负责人:Arturo Casadevall
-
依托单位:
Conjugate vaccines for prevention and treatment of cryptococcosis
-
批准号:10339408
-
项目类别:
-
资助金额:$69.24万
-
财政年份:2020
-
负责人:Arturo Casadevall
-
依托单位:
Conjugate vaccines for prevention and treatment of cryptococcosis
-
批准号:10582699
-
项目类别:
-
资助金额:$69.24万
-
财政年份:2020
-
负责人:Arturo Casadevall
-
依托单位:
Conjugate vaccines for prevention and treatment of cryptococcosis
-
批准号:10117191
-
项目类别:
-
资助金额:$74.24万
-
财政年份:2020
-
负责人:Arturo Casadevall
-
依托单位:
Biological and Clinical Impact of Cryptococcal Extralcellular Vesicles
-
批准号:8958486
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2014
-
负责人:Arturo Casadevall
-
依托单位:
Development of new passive immunization strategies for anthrax
-
批准号:8230240
-
项目类别:
-
资助金额:$56.78万
-
财政年份:2011
-
负责人:Arturo Casadevall
-
依托单位:
Atoms-to-Animals: Structural Genomics of Immunity
-
批准号:9266109
-
项目类别:
-
资助金额:$48.07万
-
财政年份:2010
-
负责人:Arturo Casadevall
-
依托单位:
Molecular Characterization of C. neoformans Antibodies
-
批准号:8051963
-
项目类别:
-
资助金额:$44.11万
-
财政年份:2010
-
负责人:Arturo Casadevall
-
依托单位:
Atoms-to-Animals: Structural Genomics of Immunity
-
批准号:8306836
-
项目类别:
-
资助金额:$109.42万
-
财政年份:2010
-
负责人:Arturo Casadevall
-
依托单位:
Atoms-to-Animals: Structural Genomics of Immunity
-
批准号:8514011
-
项目类别:
-
资助金额:$105.59万
-
财政年份:2010
-
负责人:Arturo Casadevall
-
依托单位:
Atoms-to-Animals: Structural Genomics of Immunity
-
批准号:8708895
-
项目类别:
-
资助金额:$61.36万
-
财政年份:2010
-
负责人:Arturo Casadevall
-
依托单位:
Development of new passive immunization strategies for anthrax
-
批准号:7670792
-
项目类别:
-
资助金额:$52.95万
-
财政年份:2009
-
负责人:Arturo Casadevall
-
依托单位:
B Cell Related Prophylaxis and Therapeutics
-
批准号:7706280
-
项目类别:
-
资助金额:$83.58万
-
财政年份:2008
-
负责人:Arturo Casadevall
-
依托单位:
Mining slime mold for susceptibility genes to fungi
-
批准号:6806925
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2004
-
负责人:Arturo Casadevall
-
依托单位:
Mining slime mold for susceptibility genes to fungi
-
批准号:6915685
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2004
-
负责人:Arturo Casadevall
-
依托单位:
Biology of Fungal Melanin
-
批准号:7621215
-
项目类别:
-
资助金额:$47.84万
-
财政年份:2003
-
负责人:Arturo Casadevall
-
依托单位:
海外基金